Published Oct 13, 2026, 10:33 AM ET · Updated a month ago · 1 source
The drug disconnect between Iambic and Isomorphic
axios
·
Original Report
INFERY
Wall Street is scratching its head over Iambic Therapeutics, an AI biotech that plans to go public this week.